PETS

PETMED EXPRESS INC

PETS·716382106·US·Common Stock·Healthcare - Pharmaceutical Retailers-Activist

PETS (PETMED EXPRESS INC) is held by 34 institutional investors as of Q2 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($2.2M), VANGUARD CAPITAL MANAGEMENT LLC ($1.6M), BlackRock, Inc. ($1.1M). Net institutional sentiment: Mixed.

34
Holders
(2 Elite)
$7.4M
Total Value
41% (37)
Consensus
15 buying - 22 selling
13F: Insider & Congress: Updated regularly
PETS

Smart Money Verdict

View all
Loading verdict
Held by 34 funds
2 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 14, 2025 · Activists Aug 13, 2026 · Congress none

ActivistRenaissance Technologies LLCRenaissance Technologies LLC5.3%Aug 13, 2026
ActivistSISilverCape Investments Limited12.1%Jun 29, 2026
ActivistDIDiveroli Investment Group LLC1.8%Feb 11, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
1.1M(-4.7%)$2.2M0.0%-87.70%
0
Decreased
827,397(-0.5%)$1.6M0.0%-34.43%
0
Increased
568,255(+3.0%)$1.1M0.0%-63.31%
18
Decreased
212,170(-68.2%)$407,3670.0%-58.01%
0
Decreased
204,075(-7.9%)$391,9470.0%-89.40%
0
Decreased
138,330(-40.8%)$265,5940.0%-53.28%
0
Increased
110,481(+0.7%)$212,1240.0%-34.30%
16
Unchanged
105,173$201,9320.0%-73.48%
0
New
81,407$156,3010.0%-6.77%
31
Decreased
79,503(-37.3%)$152,6460.0%-74.25%
0
Decreased
74,127(-15.7%)$142,3240.0%-51.37%
0
Decreased
60,353(-71.0%)$115,8110.0%-79.62%
0
New
47,733$91,6470.0%-6.77%
33
Decreased
42,653(-9.4%)$81,8930.0%-86.70%
0
New
41,933$80,5110.0%-6.77%
30
New
24,845$47,7020.0%-6.77%
31
New
22,924$44,0140.0%-6.77%
31
New
13,619$26,1480.0%-6.77%
27
Decreased
12,871(-43.3%)$24,7120.0%-72.34%
0
Increased
11,604(+2.0%)$22,2820.0%-49.66%
13

Showing 1-20 of 42

1 / 3
PETSPETSPETMED EXPRESS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used